Integer Holdings Co. (NYSE:ITGR) Given Average Recommendation of "Moderate Buy" by Brokerages

Shares of Integer Holdings Co. (NYSE:ITGR - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the nine brokerages that are currently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $145.44.

A number of brokerages have commented on ITGR. Citigroup lifted their target price on shares of Integer from $130.00 to $145.00 and gave the stock a "neutral" rating in a research note on Wednesday, December 11th. Bank of America raised their price target on Integer from $135.00 to $145.00 and gave the stock a "buy" rating in a research report on Tuesday, October 1st. Truist Financial boosted their price objective on Integer from $147.00 to $163.00 and gave the company a "buy" rating in a report on Wednesday, December 11th. KeyCorp upped their target price on shares of Integer from $139.00 to $144.00 and gave the stock an "overweight" rating in a research note on Tuesday, October 15th. Finally, Piper Sandler reissued an "overweight" rating and issued a $140.00 price target (up previously from $125.00) on shares of Integer in a research report on Friday, October 25th.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Contravisory Investment Management Inc. raised its holdings in shares of Integer by 55.9% in the 3rd quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider's stock worth $29,000 after purchasing an additional 80 shares during the period. Huntington National Bank increased its stake in Integer by 8,933.3% during the 3rd quarter. Huntington National Bank now owns 271 shares of the medical equipment provider's stock worth $35,000 after buying an additional 268 shares during the period. Quest Partners LLC lifted its holdings in Integer by 3,688.9% in the 2nd quarter. Quest Partners LLC now owns 341 shares of the medical equipment provider's stock worth $39,000 after buying an additional 332 shares in the last quarter. GAMMA Investing LLC lifted its stake in shares of Integer by 74.1% in the third quarter. GAMMA Investing LLC now owns 653 shares of the medical equipment provider's stock worth $85,000 after acquiring an additional 278 shares in the last quarter. Finally, Larson Financial Group LLC increased its holdings in Integer by 20,000.0% in the third quarter. Larson Financial Group LLC now owns 1,005 shares of the medical equipment provider's stock valued at $131,000 after buying an additional 1,000 shares during the last quarter. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Integer Stock Down 0.8 %

NYSE ITGR traded down $1.12 on Friday, hitting $134.76. The stock had a trading volume of 108,715 shares, compared to its average volume of 298,880. Integer has a 52-week low of $94.56 and a 52-week high of $142.76. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.28 and a quick ratio of 2.09. The stock has a market cap of $4.52 billion, a price-to-earnings ratio of 41.59, a price-to-earnings-growth ratio of 2.02 and a beta of 1.12. The business's fifty day moving average price is $134.70 and its 200 day moving average price is $126.69.

Integer (NYSE:ITGR - Get Free Report) last released its earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 EPS for the quarter, topping analysts' consensus estimates of $1.36 by $0.07. Integer had a return on equity of 11.63% and a net margin of 6.70%. The firm had revenue of $431.42 million during the quarter, compared to the consensus estimate of $440.59 million. During the same quarter in the previous year, the company posted $1.27 earnings per share. The company's revenue was up 8.7% compared to the same quarter last year. Equities research analysts anticipate that Integer will post 5.33 earnings per share for the current year.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.